Skip to main content
NUVB logo
NUVB
(NYSE)
Nuvation Bio Inc.
$4.24-- (--)
Loading... - Market loading

Nuvation Bio (NUVB) Stock Price & Financial Analysis

Nuvation Bio Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.19 - $4.41
52-Week High$9.75
52-Week Low$1.57
Open$4.32
Volume4.62M
Average Volume (3M)4.07M
Market Cap1.59B
Shares Outstanding377.52M
Price to Sales (P/S)11.40
Price to Book (P/B)5.10
EV/EBITDA-12.49
Revenue (TTM)143.05M
Net Income (TTM)-145.99M
Free Cash Flow (TTM)-134.06M
EPS (TTM)$-0.42
Profit Margin-102.06%
Operating Margin-104.99%
Return on Equity (ROE)-45.69%
Debt to Equity0.64
50-Day MA$4.60
200-Day MA$5.04
52-Week Change121.40%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Nuvation Bio

What is the current stock price for NUVB?

As of the latest trading session, NUVB stock trades at $4.21. The 52-week range is $1.57–$9.75, with a day range of $4.19–$4.41.

What is the P/E ratio for NUVB?

The P/E ratio (Price-to-Earnings) for NUVB is shown in the Key Statistics section. This valuation metric helps compare Nuvation Bio Inc. to industry peers.

Does NUVB pay dividends?

Nuvation Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NUVB?

Based on 3 analysts, the consensus for NUVB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of NUVB?

Nuvation Bio's market capitalization is $1.59B, classifying it as a small-cap company. Nuvation Bio operates in the Healthcare sector within the Biotechnology industry.